Imetelstat


Learn more about our first-in-class, first-in-clinic, telomerase inhibitor.

Read more

 
 

Geron is built on a foundation of scientific innovation. We are developing novel therapeutics using innovative technologies and unique approaches that we believe could meaningfully address the unmet medical needs of patients with cancer. The approaches are being evaluated in clinical trials today and include:

Imetelstat


Learn more about our first-in-class, first-in-clinic, telomerase inhibitor.

Read more

Close
Form content here please :)